CAPTRUST Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,600
Closed -$1.47M 3349
2026
Q1
$1.47M Buy
+1,600
New +$1.62M ﹤0.01% 1378
2023
Q4
Sell
-5,000
Closed -$2.69K 2740
2023
Q3
$2.69K Buy
+5,000
New +$2.58M ﹤0.01% 2558

Other funds holding LLY

CAPTRUST Financial Advisors's LLY Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Eli Lilly (LLY) stake by 53% in Q2 2026, buying an estimated $109M and bringing the position to 308,951 shares worth $371M. The position accounts for 0.57% of the portfolio, ranked #31.

CAPTRUST Financial Advisors first reported a position in LLY in Q3 2017 and has held it in 36 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • CAPTRUST Financial Advisors held 308,951 shares of Eli Lilly worth $371M as of Q2 2026.
  • CAPTRUST Financial Advisors bought 106,745 Eli Lilly shares in Q2 2026, an estimated $109M.
  • Eli Lilly made up 0.57% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #31 holding.
  • CAPTRUST Financial Advisors first reported a position in Eli Lilly in Q3 2017 and has held it in 36 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.